External nasal dilator with multiple discrete dilation points

Information

  • Patent Grant
  • 10893971
  • Patent Number
    10,893,971
  • Date Filed
    Monday, October 22, 2018
    6 years ago
  • Date Issued
    Tuesday, January 19, 2021
    3 years ago
Abstract
An external nasal dilator comprises resilient and engagement elements, and includes end regions adapted to engage tissues overlaying and adjacent first and second nasal passages of a human nose. Each end region includes a plurality of resilient spring finger components separated therebetween by engagement element tab extensions. The end regions are further adapted to extend around the anatomical depression formed by the alar crease adjacent each nostril. When in use the dilator stabilizes or expands said tissues and prevents or inhibits the nasal outer walls from drawing inward during breathing.
Description
CONTINUITY AND CLAIM OF PRIORITY

This is an original U.S. patent application.


FIELD

The present invention relates generally to medical devices, and more particularly to apparatus for and methods of supporting and stabilizing or dilating external tissue in humans. As disclosed and taught in the preferred embodiments, the tissue dilator devices are particularly suitable for, and are directed primarily to, external nasal dilators for supporting, stabilizing, and dilating nasal outer wall tissues adjacent and overlying nasal airway passages of the human nose. The United States Food and Drug Administration classifies the external nasal dilator as a 510(K) Exempt [Medical] Device Class r, product code LWF, regulation No. 874,3900.


BACKGROUND

External nasal dilators (END) are well disclosed in the art and are widely available in the retail consumer markets where they are generally referred to as nasal strips or nasal dilator strips. In use the END extends over the skin surfaces of the nose, flexed across the bridge thereof and adhered to the skin surface of the nasal passage outer wall tissues on each side of the bridge.


The functional part of the END is at least one resilient member (synonymously referred to in the art as a spring, spring member, resilient band, resilient member band, spring band, or bridge) that extends along the length of the nasal dilator. When flexed, the resilient member exerts spring biasing forces that, when engaged to the nose, urge the nasal passage outer wall tissues outward, stabilizing the outer walls and expanding, or dilating, the nasal passages underneath.


Stabilized nasal outer walls and/or dilated nasal passages may beneficially affect nasal obstruction and nasal congestion by reducing nasal airflow resistance. Stabilized nasal outer walls inhibit collapse of the outer wall tissues during inhalation. Dilated nasal passages increase cross sectional area and nasal cavity volume. Stabilization and/or dilation, particularly at the nasal valve, results in a corresponding improvement in nasal breathing patency. Improved nasal patency may have beneficial effects generally, may increase oxygen uptake, may improve sleep, may reduce sleep disturbances, or may improve nasal snoring or obstructive sleep apnea (OSA). External nasal dilators have been shown to have beneficial effects for athletes, particularly in sports where a mouth-guard is worn.


SUMMARY

Nasal dilators of the present invention are capable of flexing in a direction oblique or perpendicular to a surface place thereof, such that the dilator returns to a substantially planar or pre-flexed state when released from flexure. In use the dilator stabilizes portions of the tissues extending along and adjacent the nasal passages and prevents, or at least inhibits, the tissues from drawing inward during breathing, particularly at the nasal valve. The dilator expands, or dilates, the nasal passages. The nasal dilator adheres comfortably to skin surface of the nose and is easily removed with little or no stress thereto.


Nasal dilators of the present invention use spring finger components extending outward from a resilient member mid-section component to engage multiple discrete dilation points overlaid or adjacent along the first and second nasal passages. Resiliency, or spring biasing forces, generated by the nasal dilator is distributed from the resilient member mid-section to the spring fingers, and by extension, to the multiple discrete dilation points: upper spring fingers extend up and away from the nasal valve area; middle spring fingers extend substantially over and in line with the nasal valve; lower spring fingers extend away and downward from the nasal valve area to the nasal vestibule area toward the nostril opening.


By directing total spring biasing forces in this manner, stabilization and/or dilation is directed to a greater portion of the nasal passages compared to a nasal dilator in which a substantially rectangular resilient member(s) overlays only the tissues directly over the nasal valve. The nasal dilator resilient element may be longitudinally separated into two or three individual resilient members, or a single resilient member may be slotted to form from three to six resilient branches extending horizontally outward from near the center of the mid-section. Additionally, first and second end regions of the nasal dilator are configured to extend around the curvature of the nostril so as to avoid spanning the anatomical depression formed by the alar crease of the nose.


Nasal dilators of the present invention have separate resilient and engagement elements combined into a single body truss. The engagement element functions primarily to affix, adhere, or engage the dilator to the skin surfaces of the nose. The engagement element, by itself, provides little or no nasal dilation (although depending on the material used, could provide some stabilization to the nasal passage outer walls). The resilient element, by itself and flexed across the bridge of the nose, generally will not remain well-engaged thereto. Thus, nasal dilators of the present invention preferably comprise both resilient and engagement elements.


The nasal dilator, formed as a single body truss, comprises a laminate of vertically stacked material layers, including: a base layer comprising at least one base member, a resilient layer comprising at least one resilient member, and a cover layer comprising at least one cover member. The base and cover layers, either separately or combined, together with a biocompatible adhesive disposed thereon for engaging the skin, provide the primary engagement element of the nasal dilator. Where the base layer has significantly less surface area than the cover layer, adhesive on the skin-engaging side of the base layer may be optionally eliminated. With or without adhesive, the base layer may also serve as a compressible buffer between the nasal dilator and the skin engaged thereby, as has been historically common in medical devices which remain in contact with the skin for any length of time. The resilient layer may optionally adhesively engage the skin directly.


Dilator layers may be secured to each other by any suitable means such as stitching or fastening, heat or pressure bonding, ultrasonic welding, or the like, but are preferably laminated by an adhesive substance disposed on at least one flat surface side of at least one layer. At least a portion of one flat surface of the base or cover layer is preferably laminated to one of two flat surfaces of the resilient layer.


TERMINOLOGY AND ILLUSTRATION NOTES

The terms spring biasing, spring biasing force, spring force, resiliency, spring constant, etc. as used herein are generally synonymous. Nasal dilators of the present invention may generate spring biasing force in a range of from about 15 grams to about 60 grams. A preferred range is from about 15 grams to about 35 grams for non-athletes, and from about 25 grams to about 45 grams for use in training, conditioning and competition by athletes. Less than 15 grams of spring biasing may not provide enough stabilization or dilation for some users, while greater than 35 grams may be uncomfortable for non-athletic use, such as during sleep, work or study.


The nasal dilator resilient member is semi-rigid; it is flexible out-of-plane with very little or no in-plane elongation. Strictly speaking, the term resilient may be used to describe objects that exhibit either ‘flexure’ or ‘elasticity’. For purposes of the present invention, however, the terms resilient, resiliency, spring biasing, etc., mean flexure out-of-plane, in a direction perpendicular or oblique to the surface plane, while being substantially rigid in-plane. This is different from, for example, an elastic web that stretches in a direction parallel to its surface plane, even though both the elastic web and the nasal dilator resilient member may return at least substantially to their initial positions after stretch or flexure, respectively. Nasal dilators herein may be described as “capable of flexing” (when the dilator is in an initial or un-flexed position), or “flexed” (when the dilator is engaged to the nose of a user).


The present invention is not limited to the illustrated or described embodiments, which are examples of forms of the present invention. All structures and methods that embody similar functionality are intended to be covered hereby. The nasal dilators depicted, taught, enabled and disclosed herein represent new, useful and non-obvious nasal dilator devices having a variety of alternative embodiments. Some embodiments of the present invention may refer to, or cross reference, other embodiments. It may be apparent to one of ordinary skill in the art that nasal dilator features, construction or configuration may be applied, interchanged or combined between and among the preferred embodiments.


For descriptive clarity, certain terms may be used in the specification and claims: Vertical refers to a direction parallel to thickness, such as the thickness of a finished article, a member or component, or a laminate. Horizontal refers to length or longitudinal extent, such as that of a finished article or element thereof, or a direction parallel thereto. Lateral refers to its width or lateral extent. Longitudinal also refers to length, perpendicular to width or lateral extent. A longitudinal centerline is consistent with the long axis of a finished device, element, member or layer, bisecting its width midway between the long edges. A lateral centerline bisects the long axis midway along its length, perpendicular to the longitudinal centerline. The terms upper and lower refer to object orientation, particularly in plan views, relative to the top and bottom of the drawing sheet.


Broken lines and dashed lines may be used in the drawings to aid in describing relationships or circumstances with regard to objects:

    • A broken line including a dash followed by three short spaces with two short dashes therebetween indicates separation for illustrative purposes, such as in an exploded view, or to indicate an object or objects removed or separated from one or more other objects, primarily for illustrative clarity.
    • A dashed line (sometimes referred to as a shadow line) of successive short dashes with short spaces therebetween may be used to illustrate an object or element generically, to illustrate one object underneath another, or to reference environment such as facial features; or for clarity, to show location, such as the space an object or structure will occupy, would occupy, did occupy or may occupy; or for illustrative purposes, to represent an object, structure, element or layer(s) as transparent so that other objects more pertinent to the discussion at hand may be highlighted or more clearly seen.
    • A broken line including a long dash followed by a short space, a short dash and another short space is used to call out a centerline or an angle, or to indicate alignment; when accompanied by a bracket, to call out a section, segment or portion of an object or a group of objects; to illustrate a spatial relationship between one or more objects or groups of objects, or to create separation between objects for the purpose of illustrative clarity.


In the drawings accompanying this disclosure like objects are generally referred to with common reference numerals or characters, except where variations of otherwise like objects must be distinguished from one another. Where there is a plurality of like objects in a single drawing figure corresponding to the same reference numeral or character, only a portion of said like objects may be identified. After initial description in the text, some reference characters may be placed in a subsequent drawing(s) in anticipation of a need to call repeated attention to the referenced object. Where a feature or element has been previously described, shadow lines, or dashed lines, may be used to generically illustrate the feature or element together with a generic reference character. Drawings are rendered to scale—particularly plan views—but may be enlarged from actual size for illustrative clarity. Similarly, thickness may be slightly exaggerated for illustrative clarity.





BRIEF DESCRIPTION OF DRAWINGS


FIG. 1 is a perspective view of a nasal dilator in accordance with the present invention flexed across a human nose, the nose seen as a portion of a human face.



FIG. 2 is an exploded perspective view of the nasal dilator of FIG. 1.



FIG. 3 is an exploded perspective view of a nasal dilator in accordance with the present invention.



FIG. 4 is a perspective view of a nasal dilator in accordance with the present invention.



FIG. 5. is a perspective view of a nasal dilator in accordance with the present invention.



FIG. 6 is a detail view of one end of the dilator of FIG. 5.



FIG. 7 is a detail view of another end of a dilator of the present invention.



FIG. 8 is a plan view of a nasal dilator in accordance with the present invention.



FIG. 9 is a perspective view of a human nose showing several muscles thereabout.



FIG. 10 is a perspective view of a human nose showing positioning of the nasal dilator of FIG. 1 relative to the several muscles thereabout.



FIG. 11 is a frontal view of the human nose showing by stippling an anatomical depression, or valley, adjacent each nostril thereof.



FIG. 12 is a perspective view of a nasal dilator in accordance with the present invention flexed across a human nose.



FIG. 13 is a plan view of the nasal dilator of FIG. 12.



FIG. 14 is an exploded perspective view of a nasal dilator similar to that shown in FIGS. 11 and 12.



FIG. 15 is a plan view of a nasal dilator in accordance with the present invention.



FIG. 16 is a perspective view of the nasal dilator of FIG. 15 engaged to a human nose.



FIG. 17 is a plan view of a nasal dilator in accordance with the present invention.



FIG. 18 is a perspective view of the nasal dilator of FIG. 17 engaged to a human nose.



FIG. 19 shows plan views of prior art nasal dilators.



FIG. 20 is a plan view of the nasal dilator of FIG. 1.



FIG. 21 is a plan view of the nasal dilator of FIG. 13.



FIG. 22 is a plan view of the nasal dilator of FIG. 15.



FIG. 23 is a table that originally appeared in the Specification at [0065].



FIG. 24 shows two related graphs that originally appeared in the Specification at [0068] and [0069].





DETAILED DESCRIPTION

Embodiments of a nasal dilator, 10, in accordance with the present invention are illustrated in FIGS. 1-8, 10, 12-18 and 20-22.



FIG. 1 shows dilator 10 flexed across a human nose, 11, seen as a portion of a human face. FIG. 2 illustrates that dilator to comprises a laminate of vertically stacked layers that may include: a base layer comprising at least one base member, 14, a resilient layer comprising at least one resilient member, 22, a cover layer comprising at least one cover member, 18. A protective layer of release liner, not shown, removably covers exposed adhesive from dilator 10 preliminary to application to nose 11.


The peripheral dimensions of dilator 10 may be defined by the cover layer, the base layer, or a combination thereof. As seen in FIG. 2, for example, the base and cover layers may have the same plan view, or peripheral shape, as each other. Alternatively, as seen in FIG. 3, for example, the base and resilient layers may be identical. In other embodiments, all three layers may have different peripheral shapes.


Dilator layers may be stacked, or vertically arranged such that the base and cover layers are reversed, or the base layer or cover layer may be eliminated in whole or in part. As seen in FIG. 4, for example, the cover layer is eliminated, so resilient member 22 is uppermost in the stacking order of dilator layers and is exposed and visible when the dilator is engaged on the user's skin.


The preferred materials for the base and cover members may be selected from a range of widely available, preferably medical grade, flexible nonwoven synthetic fabrics or thermoplastic films that are, most preferably, breathable and comfortable on the skin. Any suitable fabric or thermoplastic film, including high Moisture Vapor Transmission Rate (MVTR) polyurethane film, may be used. A pressure sensitive adhesive, preferably biocompatible with external human tissue, may be disposed on at least one flat surface side of the material, in which case a protective, removable, release liner may cover the adhesive to protect it until the user is ready to apply the device.


The at least one resilient member 22 provides resiliency in the form of spring biasing forces as discussed hereinbefore. Resiliency is defined herein as being flexible out-of-plane while remaining substantially rigid in-plane when the dilator is flexed across the bridge of the nose. The preferred material for the resilient member is a thermoplastic resin, which may be selected from a range of thermoplastics having flexural, tensile and elastic moduli so as to have substantial in-plane rigidity and out-of-plane flexibility such that the resilient member has suitable spring biasing properties at a thickness, for example, of from about 0.005″ to about 0.015″. The most preferred thermoplastic material is a biaxially oriented polyester resin, Poly(ethylene terephthalate) or PET (or boPET). PET is used in a number of medical device applications, is particularly suitable for nasal dilator devices, and is widely available as a medical/industrial commodity.


The combined layers of dilator to form a unitary, or single body, truss. FIG. 5 delineates by brackets and dashed lines the regions of dilator to, including a first end region, 32, a second end region, 34, and an intermediate region, 36, which separates first end region 32 from second end region 34. Portions of any dilator layer may define a region or a portion thereof, and the layers, members or components of dilator to may extend from one region to another. In many embodiments, the width of intermediate region 36 is narrower than the wider end regions 32 and 34, and its length is greater than the length of either end region. In other words, end regions 32 and 34 each represent less than ⅓ of the overall dilator length, and intermediate region 36 represents more than ⅓ of the overall dilator length. End regions 32 and 34 are configured to engage soft tissues associated with the first and second nasal passages, respectively.


Resilient member 22 includes a plurality of spring finger components, 23a, 23b and 23c, extending outward from each end of the resilient member mid-section, 21. These are identified in FIG. 6. Mid-section 2t extends along intermediate region 36 of dilator 10 and has long edges substantially parallel to a longitudinal centerline, c, thereof. Opposing ends of mid-section 21 terminate at or near the boundary separating end region 32 or 34 from intermediate region 36. Thus resilient spring fingers 23 preferably extend entirely within either end region of dilator 10. Spring fingers 23a and 23c, respectively, diverge or branch from longitudinal centerline cat two separation points, 25a and 25b, as seen in FIG. 6. Separation point 25b is positioned further horizontally outward from mid-section 21 than separation point 25a.


Spring fingers 23 extend outward with, and are adjacent to, engagement element tab extensions, 30a, 30b, 30c and 30d. Thick, dark lines in FIG. 6 illustrate the surface area extents of tab extensions 30, each positioned immediately adjacent to one or both sides of each spring finger, such that the spring fingers are interposed therebetween. Tab extensions 30 are part of the engagement element of dilator 10, securing end regions 32 and 34 to nose 11 in the presence of spring biasing forces generated by resilient member 22. The terminal ends of spring fingers 23 are preferably set inward from the tab extension ends, the tab extension ends thus extending beyond the spring finger terminal ends. The tab extension ends may widen so as to extend toward one another without touching, and may extend slightly around the terminal ends of the spring fingers, a short distance therefrom and without touching, such that each tab extension is separate and distinct.


As depicted in FIGS. 6 and 8, spring fingers 23a and 23c diverge at an angle of about 35 degrees and about 60 degrees, respectively, from longitudinal centerline c. The divergent or branching angle, the positioning of separation points 25a and 25b, and the length of spring fingers 23, combine to direct spring biasing forces to discrete dilation points along the nasal passages of nose 11. Together with the surface area of tab extensions 30, this configuration results in a wider resilient element and a wider end region compared to a nasal dilator having a substantially rectangular resilient element. Greater width together with a total of four tab extensions 30 equates to a greater surface area of end regions 32 and 34, and allows dilator 10 to be more securely engaged to nose 11, compared to a nasal dilator having just two tab extensions positioned one each adjacent and outside a plurality of closely parallel resilient members (as seen, for example, in FIG. 19). Further comparison between nasal dilators of the present invention and prior art nasal dilators may be found hereinbelow, relative to FIGS. 19-22.


As seen particularly in FIG. 7, the terminal ends of spring fingers 23 are coextensive with and on a common peripheral edge, 31, with portions of the dilator engagement element thereat. (As described hereinbefore, the engagement element may comprise a base layer, cover layer, or both.) Broken lines in the exploded perspective views of FIGS. 2, 3, and 14 also indicate the common peripheral edge alignment of spring finger terminal ends to the engagement element of dilator 10.


The total resiliency, or spring biasing forces, distributed by dilator 10 extend through mid-section 21 and spring fingers 23 to multiple discrete dilation points along the first and second nasal passages, as described hereinbefore. These dilation points are associated with several muscles about nose 11, as shown in FIGS. 9 and 10: the transverse portion of the nasalis muscle, 11a, the alar portion of the nasalis muscle, 11b, the dilator naris anterior muscle, 11c, and the levator labii superioris muscle, 11d. It is held that “The dilator naris muscle, the nasalis muscle and the apicis nasi muscle are strongly related to respiration, contributing to the prevention of collapse of the nasal valve.” (Bruintjes T D, Van Olphen A F, Hillen B, Weijs W A. Electromyography of the human nasal muscles. Eur Arch Otorbinolaryngol 1996; 253:464-469.)


As more particularly seen in FIG. 10, spring finger 23C extends downward from the nasal valve area along a portion of naris muscle 11C; spring finger 23a extends up and away from the nasal valve area across a portion of transverse nasalis muscle 11a; and spring finger 23b extends substantially over and along the nasal valve along alar nasalis muscle 11b. Spring fingers 23 and tab extensions 30 extend, or direct, stabilization and dilation to this greater portion of the nasal passages compared to a nasal dilator in which a substantially rectangular resilient member(s) overlays only the tissues over the nasal valve.


The engagement element, e, of dilator 10 may be depicted by shadow lines, as seen in FIGS. 10, 12, and 13-18. Engagement element e may comprise a layer or any combination of layers that make up the engagement element of dilator to as described herein. The dilator engagement element is referenced generically in this manner to avoid repeating the several stacking orders of dilator layers previously discussed with respect to FIGS. 2-4.


An anatomical depression, or valley, d, adjacent each nostril of nose 11 is shown by stippling in FIGS. 1, 11-12, 16 and 18. Valley d is roughly triangular in shape; bounded from top to bottom by the vertical alar groove, the supra alar groove and alar facial crease (or groove). The triangular base, on top, has the shallowest depression, and the tip of the triangle, at the bottom, has the deepest.


It will be apparent to one of ordinary skill in the art that where a portion of nasal dilator surface area extends across or spans the anatomical depression, the nasal dilator will thus be non-engaged to the skin surface thereat. Areas of non-engagement can lead to the nasal dilator having a greater propensity to prematurely disengage, or peel, from the nose during use. Accordingly, the end regions of dilator 10 are configured to extend around, and particularly, to avoid extending across, or spanning, valley d, so as to maximize skin surface contact of dilator 10 to nose 11. FIG. 12 particularly illustrates by a bracket and broken lines that valley d is thus bordered by inside long edges of tab extensions 30b and 30c and a portion of the lateral end edge of dilator to corresponding to terminal ends of spring fingers 23b.


The resilient layer of dilator 10 may be bisected lengthwise into two parts, as described hereinbefore, to form separate resilient members 22a and 22b, as seen in FIGS. 12 and 13. Each resilient member has two spring fingers 23a and 23b extending from each end of mid-section 21. Thus each end region of dilator 10 includes four spring fingers and four tab extensions. Spring fingers 23a diverge obliquely, while spring fingers 23b are substantially parallel to longitudinal centerline c. As described hereinbefore, resilient spring fingers 23 are preferably confined within each end region of dilator to.


In lieu of being bisected lengthwise into two parts, a single resilient member 22 may be slotted to form four resilient branches. FIG. 14 shows a slot, 27, extending inward from at least one resilient member lateral end edge. Slot 27 may extend to, short of, or beyond, the boundary between either end region 32, 34 and intermediate region 36 of dilator to. As shown, slot 27 extends into mid-section 21, past said boundary. Slot 27 may be formed coextensively in both resilient member 22 and at least one layer of the engagement element. Alternatively, slot 27 may be formed in just the resilient member (not shown). Each resilient branch formed by slot 27 includes two spring fingers 23a and 23b. Otherwise, end regions 32 and 34 may retain substantially the same configuration of tab extensions and spring fingers as seen in FIGS. 12 and 13. It should be apparent to those of ordinary skill in the art that slot 27 may alternatively take the form of a slit, for example, or an elongated notch or other opening or material separation.


The resilient layer of dilator 10 may be trisected lengthwise into three separate resilient members, 22a, 22b and 22c, as illustrated in FIGS. 15 and 16. Resilient members 22a and 22c have a single spring finger, 23a and 23b, respectively, extending from each end of mid-section 21. Resilient member 22b has two spring fingers, 23a and 23b, diverging from each end of mid-section 21. FIG. 15 further illustrates that, from top to bottom, spring fingers 23a diverge obliquely about 25 degrees and about 60 degrees, respectively, from a centerline c; spring fingers 23b diverge slightly from centerline c, about 5 degrees and 3 degrees, respectively. The slight divergence of spring fingers 23b creates more space for extending tab extensions 30b and 30c around valley d.


A single resilient member 22 may be notched and/or slotted to form six resilient branches extending outward from the center of mid-section 21, as seen in FIGS. 17 and 18. Slots 27 comprise both an elongated notch and a slot, and may extend to, short of, or beyond, the boundary between either end region and intermediate region 36 of dilator to. FIGS. 17 and 18 show slots 27 extending into mid-section 21, past the separating boundary. Slot 27 may be formed coextensively in both resilient member 22 and at least one layer of the engagement element. Alternatively, slot 27 may be formed in just the resilient member. A resilient branch may include spring fingers, or may include divergent end portions. As shown, resilient member 22 is slotted to form a similar end region configuration as that depicted in the embodiment of FIGS. 15 and 16.


Bisecting or slotting the resilient element allows dilator 10 to have greater overall axial/torsional flexibility about its longitudinal centerline. Greater flexibility allows dilator 10 to better conform to contours of the nose and to better balance spring biasing forces between tab extensions 30a/30b and 30c/30d, respectively, on each side of the centerline. Additionally, a slotted resilient member 22 forms a contiguous area extending between the long edges at the center of mid-section 21. The contiguous area may generate greater spring biasing forces thereat compared to a bisected/trisected resilient layer.



FIGS. 19-22 compare overall dimensions and aspect ratios of prevalent prior art nasal dilators to that of nasal dilators of the present invention. As noted hereinbefore, nasal dilators of the present invention are drawn to scale. The prior art nasal dilators depicted in FIG. 19, being widely available to the public and thus physically measurable, are also drawn to scale. Both the prior art nasal dilators and nasal dilators of the present invention are drawn to size relative to each other.


As shown in FIG. 19, the prior art nasal dilators have two or three closely adjacent parallel resilient bands and four tab extensions, x, at each of four corners thereof. External nasal dilators having this configuration account for the vast majority of all external nasal dilators sold in the U.S. consumer market since 1995, as may be found, for example, in data from the Nielsen Company, US, LLC retail measurement services. The three-band nasal dilator is disclosed in U.S. Pub. No. 20110000483, and the two-band nasal dilator is disclosed in U.S. U.S. Pat. No. 5,533,503.


These prior art nasal dilators have very similar resiliency to that of dilator 10: U.S. Pub. No. 20110000483 teaches that “The total spring force delivered by the resilient element as a whole should be from about 15 grams (gm) to about 60 gm. In one embodiment, the total spring force delivered by the resilient element as a whole should be from 25 gm to about 35 gm.” U.S. Pat. No. 5,533,503 teaches that “A desired functional range of dilating force (i.e., the spring biasing force due to the resiliency of the resilient means of the nasal dilator) is typically in the range of 5 to 50 grams . . . The nasal dilator 10, of the present invention, is constructed to produce from 20 to 30 grams of dilating spring biasing force . . . ” (Additionally, U.S. Pat. No. 5,533,503 provides dimensions for its two resilient members: “The first and second resilient hands 30a and 30b are each formed of a plastic material . . . that is approximately 0.080″ to 0.135″ wide and 0.010″ thick.”) The range of spring biasing force delivered by nasal dilators of the present invention, as described herein, is substantially the same as the prior art nasal dilators.


Nasal dilators of the present invention apply spring biasing forces to a greater area of the nasal passages, and withstand the same or greater spring biasing forces compared to the prior art nasal dilators, due to greater end region width and greater surface area formed by the configuration of spring fingers 23 and tab extensions 30. The prior art dilators include upper and lower tab extensions x one to each outermost side of either two or three parallel adjacent resilient members. By comparison, nasal dilators of the present invention have three or four spring fingers interposed between four tab extensions at each end region.


A standard unit of measure (1.0) is used in FIGS. 19-22 to compare length and width dimensions of the nasal dilators to each other: overall width, o, (o=1.0) resilient element width, w, (w=1.0) and overall length, l(l=1.0). Comparative values are shown in the table at FIG. 23.


It may be apparent to those of ordinary skill in the art that, since the length of an external nasal dilator generally spans the width of the average human adult nose from nostril to nostril, there is relatively little difference in the l dimension between the prior art nasal dilators and nasal dilators of the present invention; that difference is less than 10%. However, there are significant differences in the o and w dimensions between dilator 10 and the prior art nasal dilators. For example, dilator 10 of FIG. 21 has a 73% greater overall width compared to the overall width of the prior art two-band nasal dilator, and its resilient element width is 110% greater compared to the resilient element width of the prior art two-band nasal dilator.


Thus there are significant differences in aspect ratios l:o and l:w between the prior art nasal dilators and nasal dilators of the present invention, as detailed in the table and charts below. (For this purpose, width dimensions o and w are expressed as l; overall length l is expressed as a multiple thereof.) For example, the ratio of overall length to overall width of the prior art two-band nasal dilator is 3.42:1, and its ratio of overall length to resilient element width is 7.44:1. That is, the overall length of the prior art two-band nasal dilator is 3.42 times greater than its overall width, and is 7.44 times greater than its resilient element width:
















ASPECT
ASPECT



RATIO (l:o)
RATIO (l:w)




















PRIOR ART TWO-BAND
342:1
7.44:1



PRIOR ART THREE-BAND
2.70:1
5.46:1



DILATOR 10, FIG. 20
2.30:1
3.59:1



DILATOR 10, FIG. 21
1.91:1
2.72:1



DILATOR 10, FIG. 22
2.03:1
2.98:1










Nasal dilators of the present invention have an aspect ratio of overall length to overall width (l:o) that is somewhat lesser than that of the prior art nasal dilators, as more particularly illustrated in the first chart at FIG. 24, 2401.


Furthermore, the aspect ratios of overall length to resilient element width (l:w) is considerably lesser in nasal dilators of the present invention compared to the prior art nasal dilators, as shown in the second chart at FIG. 24, 2402.


Accordingly, nasal dilators of the present invention have a preferred aspect ratio of overall length to overall width (l:o) in a range of from about 1.80-2.50 to 1, wherein the ho aspect ratios of the prior art nasal dilators are outside this range, being from 2.70-3.42 to 1.


Additionally, the preferred aspect ratio of overall length to resilient element width (l:w) of dilator 10 is in a range of from about 2.50-3.80 to 1, wherein the l:w aspect ratios of the prior art nasal dilators are well outside this range, being from 50.46-70.44 to 1.


As illustrated and described in examples of the preferred embodiments, the present invention provides novel and non-obvious articles for dilating external tissue, particularly in the form of external nasal dilator devices.

Claims
  • 1. A nasal dilator comprising: an engagement element comprising at least one engagement layer having a peripheral edge, the peripheral edge defining an intermediate region and opposing end regions including tab extensions thereof, the intermediate region having a greater length than either end region;a resilient element capable of providing spring biasing forces, the resilient element comprising at least one mid-section and a plurality of spring fingers extending horizontally outward from each end of the at least one mid-section, the plurality of spring fingers numbering at least three spring fingers;wherein the at least three spring fingers are interposed between four separate and distinct tab extensions;wherein terminal ends of the spring fingers terminate along portions of the at least one engagement layer peripheral edge;wherein the resilient element is bilaterally symmetric; andwherein a first centerline of a first spring finger intersects a second centerline of a second spring finger at an intersection point, said intersection point lying in a lateral-most one-fourth to one-third of the resilient element.
  • 2. The nasal dilator of claim 1, wherein the at least one engagement layer is selected from the group consisting of: a) a base member;b) a cover member; orc) a base member and a cover member.
  • 3. The nasal dilator of claim 1 wherein at least some of the spring fingers diverge obliquely from a longitudinal centerline of the nasal dilator, such that when the nasal dilator is in use on a nose of a user at least one of an upper spring finger extends up and away from the nasal valve area, at least one of a middle spring finger extends substantially over and along the nasal valve, and at least one of a lower spring finger extends away and downward from the nasal valve area toward the nostril opening.
  • 4. The nasal dilator of claim 1 wherein when the nasal dilator is in use on a nose of a user, a spring finger overlays and extends along an alar nasalis muscle of the nose, another spring finger overlays and extends across a portion of a transverse nasalis muscle of the nose, and another spring finger overlays and extends along a portion of a naris muscle of the nose; and wherein said muscles are strongly related to respiration and contribute to the prevention of collapse of the nasal valve, said muscles being supported by at least a portion of each of said spring fingers.
  • 5. The nasal dilator of claim 1 wherein an aspect ratio computed as length (l) to overall width (o), l:o, is less than 2.70:1.
  • 6. The nasal dilator of claim 1 wherein an aspect ratio of dilator overall length to dilator overall width is in a range between 1.8 and 2.5 to 1; and wherein an aspect ratio of dilator overall length to resilient element width is in a range between 2.5 and 3.8 to 1.
  • 7. The nasal dilator of claim 1 wherein the plurality of spring fingers extending horizontally outward is four; and wherein the four separate and distinct tab extensions are arranged such that upper and lower spring fingers have a tab extension adjacent each of two long edges, and two middle spring fingers have adjacent inside long edges absent a tab extension therebetween, a tab extension being adjacent each outside long edge thereof.
  • 8. The nasal dilator of claim 1, wherein the resilient element is split lengthwise from end to end substantially parallel to a longitudinal centerline thereof so as form two or three separate resilient members.
  • 9. The nasal dilator of claim 1, wherein the resilient element comprises a single resilient member slotted inwardly from at least one lateral end edge thereof so as to form two or three resilient branches extending from the resilient member mid-section into at least one end region.
  • 10. The external nasal dilator of claim 9 wherein a centerline of a first spring finger intersects a centerline of a third spring finger, a second spring finger lying in the lateral-most one-fourth of the branched resilient member.
  • 11. The nasal dilator of claim 1, wherein when the nasal dilator is in use on the nose of the user the opposing end regions extend around an anatomical depression adjacent each nostril of the nose, such that no portion of the nasal dilator spans the anatomical depression; and wherein the anatomical depression is defined by a vertical alar groove, a supra alar groove and an alar facial groove.
US Referenced Citations (158)
Number Name Date Kind
5476091 Johnson Dec 1995 A
5479944 Petruson Jan 1996 A
5533499 Johnson Jul 1996 A
5533503 Doubek et al. Jul 1996 A
5546929 Muchin Aug 1996 A
5549103 Johnson Aug 1996 A
RE35408 Petruson Dec 1996 E
5611333 Johnson Mar 1997 A
5653224 Johnson Aug 1997 A
5706800 Cronk et al. Jan 1998 A
5718224 Muchin Feb 1998 A
5769089 Hand et al. Jun 1998 A
5890486 Mitra et al. Apr 1999 A
5931854 Dillon Aug 1999 A
5957126 Neeser Sep 1999 A
6006746 Karell Dec 1999 A
6029658 De Voss Feb 2000 A
6058931 Muchin May 2000 A
6065470 Van Cromvoirt et al. May 2000 A
6098616 Lundy et al. Aug 2000 A
6196228 Kreitzer et al. Mar 2001 B1
6244265 Cronk et al. Jun 2001 B1
6276360 Cronk et al. Aug 2001 B1
6318362 Johnson Nov 2001 B1
6352548 Blach Mar 2002 B1
6357436 Kreitzer et al. Mar 2002 B1
6375667 Ruch Apr 2002 B1
6453901 Ierulli Sep 2002 B1
6470883 Beaudry Oct 2002 B1
6550474 Anderson et al. Apr 2003 B1
6694970 Spinelli et al. Feb 2004 B2
6769428 Cronk et al. Aug 2004 B2
6769429 Benetti Aug 2004 B1
7067710 Beaudry Jun 2006 B1
7114495 Lockwood, Jr. Oct 2006 B2
D639762 Brogden et al. Jun 2011 S
D644325 Brunner et al. Aug 2011 S
D644324 Brunner et al. Oct 2011 S
8047201 Guyuron et al. Nov 2011 B2
8062329 Ierulli Nov 2011 B2
D651710 Brogden et al. Jan 2012 S
8115049 Beaudry Feb 2012 B2
D659245 Ierulli May 2012 S
8188330 Beaudry May 2012 B2
D662203 Smith Jun 2012 S
D667543 Ierulli Sep 2012 S
D671643 Ierulli Nov 2012 S
D672461 Brogden et al. Dec 2012 S
D672872 Brunner et al. Dec 2012 S
D673270 Brunner et al. Dec 2012 S
8342173 Lockwood, Jr. Jan 2013 B2
8444670 Ierulli May 2013 B2
8584671 Ierulli Nov 2013 B2
8616198 Guyuron et al. Dec 2013 B2
8617199 Eull et al. Dec 2013 B2
8641852 Ierulli Feb 2014 B2
D707814 Ierulli Jun 2014 S
D707815 Ierulli Jun 2014 S
8834511 Holmes et al. Sep 2014 B2
8834512 Brown et al. Sep 2014 B1
8834514 Smith Sep 2014 B2
8858587 Ierulli Oct 2014 B2
D722161 Reyers Feb 2015 S
D722162 Reyers Feb 2015 S
D725772 Ierulli Mar 2015 S
D725773 Ierulli Mar 2015 S
9095422 Gray Aug 2015 B2
D738496 Peck Sep 2015 S
D739015 Martin Sep 2015 S
9119620 Peterson et al. Sep 2015 B2
D741997 Ierulli Oct 2015 S
D741998 Martin Oct 2015 S
D743544 Ierulli Nov 2015 S
D743545 Ierulli Nov 2015 S
D743565 Engel et al. Nov 2015 S
D745147 Ierulli Dec 2015 S
9204988 Fischell Dec 2015 B1
D746982 Ierulli Jan 2016 S
D747478 Brunner et al. Jan 2016 S
D753294 Guyuron et al. Apr 2016 S
D755376 Ierulli May 2016 S
D758575 Ierulli Jun 2016 S
D758576 Ierulli et al. Jun 2016 S
D759240 Ierulli Jun 2016 S
D759241 Ierulli Jun 2016 S
D759242 Ierulli Jun 2016 S
9364367 Ierulli Jun 2016 B2
9364368 Ierulli Jun 2016 B2
9381332 Judd Jul 2016 B2
D764055 Ierulli et al. Aug 2016 S
D764662 Ierulli et al. Aug 2016 S
9414957 Fischell Aug 2016 B1
9427945 Gray et al. Aug 2016 B2
D779666 Ierulli et al. Feb 2017 S
D779667 Ierulli et al. Feb 2017 S
9566183 Fischell Feb 2017 B1
D788298 Guyuron May 2017 S
9642995 Fenton et al. May 2017 B2
D789531 Ierulli Jun 2017 S
D790058 Ierulli et al. Jun 2017 S
D790695 Ierulli Jun 2017 S
D791312 Peck Jul 2017 S
D791314 Ierulli Jul 2017 S
9730827 Ierulli Aug 2017 B2
9730828 Ierulli Aug 2017 B2
9775738 Andre Oct 2017 B2
9844456 Ierulli Dec 2017 B2
9901479 Holmes Feb 2018 B2
9901480 Ierulli Feb 2018 B2
9901481 Ierulli Feb 2018 B2
D812749 Ierulli Mar 2018 S
D813387 Ierulli et al. Mar 2018 S
D814029 Ierulli Mar 2018 S
10010442 Ierulli Jul 2018 B2
20080058858 Smith Mar 2008 A1
20080097517 Holmes et al. Apr 2008 A1
20090125052 Pinna et al. May 2009 A1
20090234383 Ierulli Sep 2009 A1
20100210988 Dallison Aug 2010 A1
20100298861 Fenton Nov 2010 A1
20110000483 Matthias et al. Jan 2011 A1
20110054517 Holmes et al. Mar 2011 A1
20110166594 Eull Jul 2011 A1
20110224717 Lockwood Sep 2011 A1
20120004683 Gray Jan 2012 A1
20120022582 Guyuron Jan 2012 A1
20120067345 Shilon Mar 2012 A1
20120172923 Fenton Jul 2012 A1
20120209313 Ierulli Aug 2012 A1
20120232455 Beaudry Sep 2012 A1
20130104882 Ierulli May 2013 A1
20130118488 Ledogar May 2013 A1
20140194922 Ierulli Jul 2014 A1
20140148844 Andre Oct 2014 A1
20140296904 Andre Oct 2014 A1
20140350596 Smith Nov 2014 A1
20150005812 Holmes Jan 2015 A1
20150012035 Ierulli Jan 2015 A1
20150051636 Lockwood Feb 2015 A1
20150090398 Ierulli Apr 2015 A1
20150090399 Ierulli Apr 2015 A1
20150094757 Ierulli Apr 2015 A1
20150094758 Ierulli Apr 2015 A1
20150216709 Peck Aug 2015 A1
20150230966 Ierulli Aug 2015 A1
20150250637 Ierulli Sep 2015 A1
20150290021 Gray Oct 2015 A1
20150359654 Bentivegna et al. Dec 2015 A1
20160008161 Ierulli et al. Jan 2016 A1
20160278967 Ierulli Sep 2016 A1
20160278968 Ierulli Sep 2016 A1
20160339619 Gray et al. Nov 2016 A1
20170112653 Ierulli Apr 2017 A9
20170143531 Ierulli May 2017 A9
20170151084 Ierulli Jun 2017 A9
20180021163 Ierulli Jan 2018 A9
20180028346 Ierulli Feb 2018 A1
20180071131 Ierulli Mar 2018 A1
Foreign Referenced Citations (2)
Number Date Country
855175 Jul 1998 EP
289561 Oct 1985 ES
Related Publications (1)
Number Date Country
20200121488 A1 Apr 2020 US